AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SALTER, J. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SALTER, J. M.
Agricola
Right arrow Articles by SALTER, J. M.

American Journal of Clinical Nutrition, Vol 8, 535-539, Copyright © 1960 by The American Society for Clinical Nutrition, Inc.

Metabolic Effects of Glucagon in the Wistar Rat

JAMES M. SALTER PH.D.1

1 From the Banting and Best Department of Medical Research, University of Toronto, Toronto, Canada

Male Wistar rats, weighing 145 gm., were given injections of 40 µg. of glucagon every eight hours for twenty-two days. They gained 75 per cent less weight, synthesized much less protein and fat and retained less water than control animals restricted to the same amounts of food. The glycogen content of the livers from the treated animals was more than twice that found in the control animals. In glucagon-treated rats, the hyperglycemic response increased during the early phases of the investigation, but glucosuria and ketonuria never occurred. The treatment produced a transient increase in the urinary excretion of sodium and a sustained increase in the urinary excretion of nitrogen. Fecal nitrogen was not affected. It was also observed that glucagon reduced the insulin content of the pancreas.

The fact that glucagon-treated rats synthesize less fat and protein than untreated control animals, consuming identical amounts of food, indicates that this hormone exerts a significant influence on caloric balance.




This article has been cited by other articles:


Home page
DiabetesHome page
A. Pocai, P. E. Carrington, J. R. Adams, M. Wright, G. Eiermann, L. Zhu, X. Du, A. Petrov, M. E. Lassman, G. Jiang, et al.
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Diabetes, October 1, 2009; 58(10): 2258 - 2266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. C. Woods
Gastrointestinal Satiety Signals I. An overview of gastrointestinal signals that influence food intake
Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G7 - G13.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
W Langhans, U Zeiger, E Scharrer, and N Geary
Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon
Science, November 26, 1982; 218(4575): 894 - 896.
[Abstract] [PDF]


Home page
ScienceHome page
S. Balagura, L. Harrell, and T. Ralph
Glucodynamic Hormones Modify the Recovery Period after Lateral Hypothalamic Lesions
Science, October 5, 1973; 182(4107): 59 - 60.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1960 by The American Society for Nutrition